Cargando…
Mechanisms of gastrointestinal barrier dysfunction in COVID-19 patients
Coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a major global public health event, resulting in a significant social and economic burden. Although COVID-19 was initially characterized as an upper respiratory and pulmona...
Autores principales: | Xue, Weijie, Honda, Masaki, Hibi, Taizo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134419/ https://www.ncbi.nlm.nih.gov/pubmed/37124884 http://dx.doi.org/10.3748/wjg.v29.i15.2283 |
Ejemplares similares
-
Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19
por: Jin, Byungchang, et al.
Publicado: (2021) -
Gastrointestinal mucosal immunity and COVID-19
por: Velikova, Tsvetelina, et al.
Publicado: (2021) -
Abdominal and gastrointestinal manifestations in COVID-19 patients: Is imaging useful?
por: Boraschi, Piero, et al.
Publicado: (2021) -
COVID-19 in patients with gastrointestinal stromal tumors: Recommendations for management and vaccination
por: Snegarova, Violeta, et al.
Publicado: (2022) -
Inflammatory effect on the gastrointestinal system associated with COVID-19
por: Delgado-Gonzalez, Paulina, et al.
Publicado: (2021)